Granted Patent
B2
US 8,211,436 · App. 12/698,822 · Granted Jul 3, 2012
Anticancer vaccine and diagnostic methods and reagents
Assignees:
University of Pittsburgh—Of the Commonwealth System of Higher Education; University of Virginia Patent Foundation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention provides a method for vaccinating a patient against a malignancy comprising introducing a protein or peptide comprising of all or an immunogenic fragment of a cyclin protein into the patient. The invention further provides a method of identifying tumor antigens.
Claims (2)
1. A method of inducing immune response in a patient comprising introducing a peptide consisting of the amino acid sequence of SEQ ID NO:4 (AGYLMELCC) into a patient under conditions sufficient for the patient to develop an immune response to the peptide.
2. The method of claim 1 , wherein the patient is human.
Assignments (2)
CONFIRMATORY LICENSE
Recorded May 27, 2010
From: UNIVERSITY OF PITTSBURGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024452/0187 →
CONFIRMATORY LICENSE
Recorded May 25, 2010
From: UNIVERSITY OF PITTSBURGH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024435/0940 →
Continuity (4)
Provisional Application
60324450
· Sep 24, 2001